News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,088 Results
Type
Article (61150)
Company Profile (70)
Press Release (580868)
Section
Business (173514)
Career Advice (2727)
Deals (32396)
Drug Delivery (96)
Drug Development (76790)
Employer Resources (150)
FDA (14906)
Job Trends (13865)
News (304560)
Policy (28896)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2886)
Academic (2)
Accelerated approval (5)
Adcomms (22)
Allergies (83)
Alliances (43054)
ALS (82)
Alzheimer's disease (1298)
Antibody-drug conjugate (ADC) (95)
Approvals (14918)
Artificial intelligence (242)
Autoimmune disease (18)
Automation (13)
Bankruptcy (289)
Best Places to Work (10852)
BIOSECURE Act (15)
Biosimilars (98)
Biotechnology (51)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (249)
Cancer (1945)
Cardiovascular disease (152)
Career advice (2307)
Career pathing (32)
CAR-T (142)
Cell therapy (400)
Cervical cancer (20)
Clinical research (62222)
Collaboration (722)
Compensation (282)
Complete response letters (20)
COVID-19 (2565)
CRISPR (38)
C-suite (228)
Cystic fibrosis (98)
Data (1930)
Decentralized trials (2)
Denatured (25)
Depression (38)
Diabetes (233)
Diagnostics (6124)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (106)
Drug pricing (95)
Drug shortages (23)
Duchenne muscular dystrophy (78)
Earnings (59705)
Editorial (33)
Employer branding (18)
Employer resources (132)
Events (93691)
Executive appointments (680)
FDA (16020)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (691)
Gene editing (100)
Generative AI (19)
Gene therapy (272)
GLP-1 (641)
Government (4430)
Grass and pollen (5)
Guidances (46)
Healthcare (18196)
Huntington's disease (18)
IgA nephropathy (21)
Immunology and inflammation (96)
Indications (25)
Infectious disease (2688)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (86)
Interviews (526)
IPO (14762)
IRA (38)
Job creations (3410)
Job search strategy (1941)
Kidney cancer (9)
Labor market (26)
Layoffs (487)
Leadership (18)
Legal (6422)
Liver cancer (64)
Lung cancer (279)
Lymphoma (126)
Machine learning (4)
Management (53)
Manufacturing (243)
MASH (56)
Medical device (12610)
Medtech (12615)
Mergers & acquisitions (18152)
Metabolic disorders (582)
Multiple sclerosis (70)
NASH (13)
Neurodegenerative disease (77)
Neuropsychiatric disorders (23)
Neuroscience (1764)
NextGen: Class of 2025 (6375)
Non-profit (4312)
Northern California (2201)
Now hiring (11)
Obesity (299)
Opinion (227)
Ovarian cancer (68)
Pain (83)
Pancreatic cancer (73)
Parkinson's disease (129)
Partnered (20)
Patents (205)
Patient recruitment (97)
Peanut (50)
People (59335)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19570)
Phase II (27451)
Phase III (20062)
Pipeline (997)
Podcasts (55)
Policy (102)
Postmarket research (2469)
Preclinical (8308)
Press Release (67)
Prostate cancer (93)
Psychedelics (27)
Radiopharmaceuticals (247)
Rare diseases (341)
Real estate (5979)
Recruiting (61)
Regulatory (19959)
Reports (33)
Research institute (2394)
Resumes & cover letters (405)
Rett syndrome (4)
RNA editing (3)
RSV (33)
Schizophrenia (63)
Series A (122)
Series B (80)
Service/supplier (9)
Sickle cell disease (50)
Southern California (1949)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (28)
Startups (3337)
State (1)
Stomach cancer (9)
Supply chain (47)
Tariffs (7)
The Weekly (28)
United States (19539)
Vaccines (634)
Venture capitalists (29)
Webinars (12)
Weight loss (192)
Women's health (30)
Worklife (18)
Date
Today (106)
Last 7 days (693)
Last 30 days (2563)
Last 365 days (31005)
2025 (7807)
2024 (32269)
2023 (36330)
2022 (46607)
2021 (51560)
2020 (50713)
2019 (44763)
2018 (34058)
2017 (30713)
2016 (30059)
2015 (35435)
2014 (28372)
2013 (24951)
2012 (26211)
2011 (26452)
2010 (24930)
Location
Africa (871)
Alabama (50)
Alaska (6)
Arizona (164)
Arkansas (14)
Asia (37920)
Australia (6829)
California (5034)
Canada (1714)
China (439)
Colorado (230)
Connecticut (242)
Delaware (123)
Europe (88207)
Florida (772)
Georgia (189)
Idaho (56)
Illinois (511)
India (24)
Indiana (265)
Iowa (8)
Japan (132)
Kansas (91)
Kentucky (23)
Louisiana (8)
Maine (60)
Maryland (778)
Massachusetts (3671)
Michigan (210)
Minnesota (319)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (23)
Nevada (51)
New Hampshire (60)
New Jersey (1509)
New Mexico (29)
New York (1485)
North Carolina (914)
North Dakota (8)
Northern California (2201)
Ohio (182)
Oklahoma (15)
Oregon (35)
Pennsylvania (1126)
Puerto Rico (10)
Rhode Island (25)
South America (1174)
South Carolina (15)
South Dakota (1)
Southern California (1949)
Tennessee (89)
Texas (778)
Utah (157)
Virginia (128)
Washington D.C. (45)
Washington State (477)
West Virginia (3)
Wisconsin (53)
642,088 Results for "university of glasgow".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
November 13, 2024
·
13 min read
Press Releases
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow
November 8, 2024
·
18 min read
Press Releases
Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts Toward Ending the Epidemic
November 8, 2024
·
19 min read
Precision-Panc Team Open the PRIMUS-006 Study, a Novel Combination of IMM-101, Gemcitabine and Pembrolizumab
The Precision-Panc team at the University of Glasgow, with their Co-Sponsor, NHS Greater Glasgow & Clyde, announced the opening of the Phase II PRIMUS-006 study evaluating IMM-101, a broad-spectrum immunomodulatory agent containing heat-killed, whole cell Mycobacterium obuense, in combination with gemcitabine and pembrolizumab as first-line treatment in patients with metastatic pancreatic cancer.
June 18, 2024
·
5 min read
Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the presentation of new preclinical data at the 2024 congress of the European Society for Radiotherapy and Oncology (ESTRO).
May 6, 2024
·
5 min read
Pharm Country
Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health
Sampled1 today announced that the new genomics Sampled SMART Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc., a leading precision oncology company, to manage blood samples for a large-scale lung cancer screening study.
February 1, 2023
·
2 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
Former Apple and Intel Executive Michael Bell Joins Chemify as Chief Technology Officer
February 27, 2025
·
2 min read
Biotech Bay
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company’s upcoming new data from its HIV research and development programs to be presented at the 30th International Congress on Drug Therapy in HIV Infection (HIV Glasgow 2022) in Glasgow, Scotland and virtually from October 23-26, 2022.
October 18, 2022
·
15 min read
Biotech Bay
Orca Bio to Present Positive Clinical Data on Orca-T at the 50th Annual Meeting of the EBMT
Orca Bio today announced new data will be presented during the 50th Annual Meeting of the EBMT in Glasgow, United Kingdom.
April 11, 2024
·
4 min read
1 of 64,209
Next